Established in 2005, the company is a high-tech enterprise specializing in R&D, production and sales of biomedical molecular diagnostic reagents and instruments, and is the only company that has been certified by WHO four times and included in its official procurement list in the last four global public health emergencies (Ebola, Zika, COVID-19, monkeypox). The company is a leading molecular diagnostic enterprise with advanced technology and complete products in China, focusing on R&D, production and sales of molecular diagnostic reagents and instruments. The company's main products are molecular diagnostic reagents and instruments. Corporate honors: 2018 high-tech enterprise certificate, 2016 Shanghai High-tech Achievement Transformation Project Top 100 Certificate, etc. It won the title of “Top 50 Medical Device Companies” in the 2021-2023 China Pharmaceutical Industry's Most Influential List, and was listed as the 2023 Shanghai Top 100 Emerging Industry Enterprises, 2023 Shanghai Top 100 Private Manufacturing Enterprises, and the 2023 Shanghai Top 100 Manufacturing Enterprises.